The effects of vasoactive peptide urocortin 2 on hemodynamics in spontaneous hypertensive rat and the role of L-type calcium channel and CRFR2

Emeto, 2011, Relevance of urocortins to cardiovascular disease, J Mol Cell Cardiol, 51, 299, 10.1016/j.yjmcc.2011.06.002 Grandi, 2002, Aldosterone antagonist improves diastolic function in essential hypertension, Hypertension, 40, 647, 10.1161/01.HYP.0000036399.80194.D8 Tsotetsi, 2001, Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats, Hypertension, 38, 846, 10.1161/hy1001.092649 Bale, 2004, The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure, Proc Natl Acad Sci USA, 101, 3697, 10.1073/pnas.0307324101 Brar, 2000, Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway, J Biol Chem, 275, 8508, 10.1074/jbc.275.12.8508 Nozu, 2013, Peripheral corticotropin-releasing factor (CRF) induces stimulation of gastric contractions in freely moving conscious rats: role of CRF receptor types 1 and 2, Neurogastroenterol Motil, 25, 190, 10.1111/nmo.12050 Rivier, 2014, Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance, Front Neuroendocrinol, 35, 161, 10.1016/j.yfrne.2013.10.006 Parkes, 2001, Cardiovascular actions of CRH and urocortin: an update, Peptides, 22, 821, 10.1016/S0196-9781(01)00396-5 Rademaker, 2011, Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and rVERl effects, Hypertension, 57, 1136, 10.1161/HYPERTENSIONAHA.111.173203 Liew, 2012, Therapeutic benefit of urocortin in rats with intracerebral hemorrhage, J Neurosurg, 116, 193, 10.3171/2011.8.JNS101637 Rademaker, 2011, Urocortin 2 sustains haemodynamic and rVERl function during introduction of beta-blockade in experimental heart failure, J Hypertens, 29, 1787, 10.1097/HJH.0b013e3283493776 Kageyama, 2003, Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta, J Cardiovasc Pharmacol, 42, 561, 10.1097/00005344-200310000-00015 Rademaker, 2007, Urocorti administration from onset of rapid left ventricular pacing represses progression to overt heart failure, J Am Phys, 293, H1536 Liu, 2005, In vivo protective effects of urocortin on ischemia/reperfusion injury in rat heart via free radical mechanisms, Can J Physiol Pharmacol, 83, 459, 10.1139/y05-033 Calderón-Sánchez, 2011, Cardioprotective action of urocortin in postconditioning involves recovery of intracellular calcium handling, Cell Calcium, 50, 84, 10.1016/j.ceca.2011.05.010 Scarabelli, 2002, Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion, J Am Coll Cardiol, 40, 155, 10.1016/S0735-1097(02)01930-7 Wamhoff, 2004, L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF – dependent mechanism, Circ Res, 95, 406, 10.1161/01.RES.0000138582.36921.9e Emeto, 2014, Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2, Clin Sci (Lond), 126, 517, 10.1042/CS20130425 Kageyama, 2012, Regulation and roles of urocortins in the vascular system, Int J Endocrinol, 2012, 873723, 10.1155/2012/873723 Rademaker, 2013, Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure, Circ Heart Fail, 6, 825, 10.1161/CIRCHEARTFAILURE.112.000205 Wang, 2013, Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats, Peptides, 39, 164, 10.1016/j.peptides.2012.11.009 Chitravanshi, 2012, Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat, Am J Physiol Regul Integr Comp Physiol, 303, R1023, 10.1152/ajpregu.00224.2012 Jin, 2011, Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro, J Mol Endocrinol, 47, 219, 10.1530/JME-11-0048 Liew, 2012, Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats, Neuroinflammation, 19, 13, 10.1186/1742-2094-9-13 Novembri, 2011, Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response, Mol Hum Reprod, 17, 587, 10.1093/molehr/gar020 Chen-Scarabelli, 2013, The cardioprotective effects of urocortin are mediated via activation of the Src tyrosine kinase-STAT3 pathway, JAKSTAT, 2, e24812 Li, 2013, Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart, Proc Natl Acad Sci USA, 110, 16133, 10.1073/pnas.1312775110